Effects of hepatic insulin gene therapy on enteric neuropathy in STZ-diabetic mice

Journal of Central South University (Medical Sciences)

Volumn 36, Issue 6, 2011, Pages 546-553

  You, Shuo ^a,b   Zhang, Qing ^a   Mallappa, Anitha ^c   Jia, Dingwu ^b   Olson, Darin E ^b   Srinivasan, Shanthi ^c   Thulé, Peter M ^b   Zhou, Zhiguang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Diabetic dnteric neuropathy; Gene therapy; Proinsulin

Indexed keywords

INSULIN; PROINSULIN;

ADENOVIRUS; ANIMAL; ARTICLE; DIABETIC NEUROPATHY; EXPERIMENTAL DIABETES MELLITUS; GASTROINTESTINAL DISEASE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; INTESTINE INNERVATION; LIVER CELL; METABOLISM; MOUSE; PATHOLOGY;

ADENOVIRIDAE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPATOCYTES; INSULIN; MICE; PROINSULIN;

EID: 79960800489     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2011.06.012     Document Type: Article

References (25)

1. Verne G N, Sninsky C A. Diabetes and the gastrointestinal tract [J]. Gastroenterol Clin North Am, 1998, 27(4) : 861-874. (Pubitemid 29023062)
2. Talley N J, Young L, Bytzer P, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life [J]. Am J Gastroenterol, 2001, 96(1) : 71-76. (Pubitemid 32104810)
3. Quan C, Talley N J, Jones M P, el al. Gain and loss of gastrointestinal symptoms in diabetes mellitus : associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up[ J]. Am J Gastroenterol, 2008, 103 (8) : 2023-2030.
4. Bertolaso M, Olsson J, Picardi A, et al. Gene therapy and enhancement for diabetes (and other diseases) : the multiplicity of considerations[J]. Diabetes Metab Res Rev, 2010, 26(7) : 520-524.
5. Bagley J, Paez-Cortez J, Tian C, el al. Gene therapy in type 1 diabetes[J]. Crit Rev Immunol, 2008, 28(4) : 301-324.
6. Polakof S. Diabetes therapy; novel patents targeting the glucose-induced insulin secretion [J]. Recent Pat DNA Gene Seq, 2010, 4(1):1-9.
7. Kozlowski M, Olson D E, Rubin J, et al. Adeno-associated viral delivery of a metabolically regulated insulin transgene to hepatocytes[J]. Mol Cell Endocrinol, 2007, 273(1/2) : 6-15. (Pubitemid 47016742)
8. Olson D E, Campbell A G, Porter M H, et al. Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor rats[J]. Mol Ther, 2008, 16(7) : 1235-1242. (Pubitemid 351866054)
9. Kong M F, Horowitz M. Gastric emptying in diabetes mellitus : relationship to blood-glucose control [J]. Clin Geriatr Med, 1999,15(2) : 321-338. (Pubitemid 29235187)
10. Bharucha A E, Camilleri M, Forstrom LA, et al. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus[ J]. Clin Endocrinol (Oxf), 2009, 70(3) : 415-420.
11. Ogbonnaya K I, Arem R. Diabetic diarrhea. Pathophysiology, diagnosis, and management[J]. Arch Intern Med, 1990, 150 (2) : 262-267. (Pubitemid 20063030)
12. Kojecky V, Bematek J, Horowitz M, et al. Prevalence and determinants of delayed gastric emptying in hospitalised Type 2 diabetic patients[J]. World J Gastroenterol, 2008, 14 (10) : 1564-1569. (Pubitemid 351460173)
13. Kim J H, Park H S, Ko S Y, et al. Diabetic factors associated with gastrointestinal symptoms in patients wilh type 2 diabetes [J]. World J Gastroenterol, 2010,1 6(14) : 1782-1787.
14. Selim M M, Wendelschafer-Crabb G, Redmon J B, et al. Gastric mucosal nerve density : a biomarker for diabetic autonomic neuropathy? [J]. Neurology, 2010, 75(11) : 973-981.
15. Domschke S, Bloom S R, Adrian T E, et al. Chronic pancreatitis and diabetes mellitus : plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin) [J]. Hepatogastroenterology, 1988, 35 (5) : 229-237.
16. Ryan G J. New pharmacologic approaches to treating diabetic retinopathy [J]. Am J Health Syst Pharm, 2007, 64 (17 Suppl 12) : S15-S21. (Pubitemid 350202224)
17. Gulcelik N E, Kaya E, Demirbas B, et al. Helicobacter pylori prevalence in diabetic patients and its relationship wilh dyspepsia and autonomic neuropathy[J]. J Endocrinol Invest, 2005, 28(3) : 214-217. (Pubitemid 43162767)
18. Agrawal R P, Sharma R, Garg D, et al. Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes[J]. J Indian Med Assoc, 2010, 108(3) : 140-143.
19. Quigley E M. The pathophysiology of diabetic gastroenteropathy : more vague than vagal [J]. Gastroenterology, 1997, 113 (5) : 1790-1794. (Pubitemid 27461270)
20. Duby J J, Campbell R K, Setter S M, et al. Diabetic neuropathy : an intensive review[J]. Am J Health Syst Pharm, 2004, 61(2) : 160-173.
21. Drewes V M. Mechanical and electrical activity in the duodenum of diabetics with and without diarrhea. Pressures, differential pressures and action potentials [J]. Am J Dig Dis, 1971, 16(7) : 628-634.
22. Koch C A, Uwaifo G I. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? [J]. Eur J Gastroenterol Hepatol, 2008, 20(9) : 822-825.
23. Bell G I, Pictet R L, Rutter W J, et al. Sequence of the human insulin gene [J]. Nature, 1980, 284(5751) : 26-32. (Pubitemid 10098762)
24. Hajitou A. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector [J]. Adv Genet, 2010, 69 : 65-82.
25. Zhang J A, Jia D, Olson D E, et al. Hepatic insulin gene therapy diminishes liver glycogen despite insulin responsive transcriptional effects in diabetic CD-1 mice [J]. J Gene Med, 2009, 11(7) : 588-597.